Research and Development
Celator’s shares jump on positive late-stage trials for leukaemia drug
March 16, 2016 Business Services, Research and Development, Sales and Marketing Celator Pharmaceuticals, EMA, US FDA, Vyxeos, drug trials, phase III
FDA says benefits outweigh risks in Abbott’s heart stent, Absorb
March 16, 2016 Research and Development, Sales and Marketing Abbott, absorb, bioresorbable, coronary artery disease
Sanofi to use DiCE Molecules’ platform to boost drug discovery
March 16, 2016 Research and Development DiCE Molecules, Sanofi
Teva says closing buy of Allergan’s generics biz may take longer
March 16, 2016 Business Services, Research and Development, Sales and Marketing Allergan, M&A, MA, Pfizer, Teva
Lilly changes Alzheimer’s trial endpoint – shares fall
March 16, 2016 Research and Development Alzheimer's disease, Eli Lilly, solanezumab
InVivo Therapeutics to sell stake in company; shares drop
March 15, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing InVivo Therapeutics, Stake sale, stocks
PTC Therapeutics to file new Phase III data for genetic muscle disorder drug in Canada
March 15, 2016 Manufacturing and Production, Research and Development Canada, PTC Therapeutics, Translarna, nonsense mutation Duchenne muscular dystrophy, phase III
Adocia and Lilly report positive early results for ultra-rapid insulin
March 15, 2016 Manufacturing and Production, Research and Development Adocia, BioChaperone Lispro, Eli Lilly, insulinm
UPDATE: Pfizer gets interim stay on cough syrup ban
March 15, 2016 Manufacturing and Production, Research and Development Abbott Laboratories, Corex, Pfizer, Pfizer India
Genentech cancer immunotherapy gets Priority FDA Review in bladder cancer
March 15, 2016 Manufacturing and Production, Research and Development FDA, Genentech, Roche, atezolizumab, bladder cancer, priority review
GW Pharma shares more than double after positive Phase III trials for epilepsy drug
March 15, 2016 Manufacturing and Production, Research and Development Epidiolex, GW Pharma, US FDA, epilepsy in children, phase III
Janssen’s Zytiga boosts survival in early-stage prostate cancer
March 14, 2016 Research and Development, Sales and Marketing Janssen, Zytiga, abiraterone, prednisone, prostate cancer
FDA approves Pfizer sNDA for Xalkori
March 14, 2016 Research and Development, Sales and Marketing Cancer, EMA, NSCLC, Pfizer, Xalkori (crizotinib)
EMA starts review of Gilead Sciences’ Zydelig following safety concerns
March 14, 2016 Research and Development, Sales and Marketing EMA, Gilead Sciences, blood cancer, clinical trials, zydelig
GSK terminates Five Prime Therapeutics mesothelioma collaboration
March 14, 2016 Research and Development, Sales and Marketing Five Prime Therapeutics, GSK, mesothelioma
